Home > Financial Ratios > VENUS REMEDIES

VENUS REMEDIES
Working Capital/Sales

    Back to All Ratios
COMMUNITY POLL
for VENUS REMEDIES
Please provide your vote to see the results

VENUS REMEDIES Last 5 Year Working Capital/Sales History

[Consolidated]

Mar2026Mar2025Mar2024Mar2023Mar2022
   Working Capital/Sales(x) 3.302.512.152.313.24

What is the latest Working Capital/Sales ratio of VENUS REMEDIES ?

The latest Working Capital/Sales ratio of VENUS REMEDIES is 3.30 based on Mar2026 Consolidated results.
Year Working Capital/Sales
Mar20263.30
Mar20252.51
Mar20242.15
Mar20232.31
Mar20223.24

How is Working Capital/Sales of VENUS REMEDIES Trending?

Years Working Capital/Sales % Change
Mar2026 3.3
31.47
Mar2025 2.51
16.74
Mar2024 2.15
-6.93
Mar2023 2.31
-28.70
Mar2022 3.24 -

Other Financial Ratios of VENUS REMEDIES


Compare Working Capital/Sales ratio of peers of VENUS REMEDIES

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
VENUS REMEDIES ₹2,237.9 Cr 4.8% 3.5% 278.5% Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹444,717.0 Cr -0.8% -2.5% 11.9% Stock Analytics
DIVIS LABORATORIES ₹255,115.0 Cr 1.9% 6.6% 55.1% Stock Analytics
TORRENT PHARMACEUTICALS ₹189,613.0 Cr 0.3% 2% 35.9% Stock Analytics
CIPLA ₹112,876.0 Cr 0.9% -0.8% -10.9% Stock Analytics
DR REDDYS LABORATORIES ₹100,395.0 Cr 0.1% 1.4% -9.3% Stock Analytics


VENUS REMEDIES Share Price vs Sensex


Share Price Returns(%) 1 Week 1 Month 1 Year
VENUS REMEDIES

4.8%

3.5%

278.5%

SENSEX

-0.5%

-4.8%

-11%


You may also like the below Video Courses